Clinical Trials
3 trialsNCT05042791 2024-02-09
A Study of Pyrotinib Plus Capecitabine Combined With SRT in HER2+ MBC With Brain Metastases
Jiangxi Provincial Cancer Hospital
Phase 2 Unknown
NCT05188495 2022-01-12
HELP
Peking University Cancer Hospital & Institute
Unknown
NCT04385563 2020-05-13
A Study to Evaluate the Efficacy and Safety of the Combination of TQ-B211 Plus Docetaxel in Patients With HER2-positive MBC.
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 3 Unknown